Frazier Life Sciences Acquisition Corp. II
corporate_fare Company Profile
Frazier Life Sciences Acquisition Corp. II (NASDAQ:FLSC) is a publicly traded company in the Energy & Transportation sector. Wiseek has independently scored 2 items for FLSC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-15, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for FLSC spans 8-K, 424B4.
Recent high-impact activity:
- Frazier Life Sciences SPAC II Closes $75M IPO, Adds $3M Sponsor Placement and $25M Forward Purchase
- Frazier Life Sciences SPAC II Prices $75M IPO at $10.00/Share
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 17,259 shares in FLSC as of the October 15, 2026 settlement, a 100.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 30, 2026, 6.0% of FLSC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for FLSC, detected from its recent SEC filings · based on capital-structure filings through 2026-10-14.
$75M SPAC IPO Priced · Sponsor Founder Share Dilution
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →